{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T15:23:31Z","timestamp":1771687411040,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00063-019-0561-z","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T14:03:24Z","timestamp":1552313004000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Permeables Foramen ovale (PFO) als Todesursache","Patent foramen ovale with a license to kill"],"prefix":"10.1007","volume":"115","author":[{"given":"B.","family":"Meier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"key":"561_CR1","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1093\/eurheartj\/ehu232","volume":"35","author":"J Abecasis","year":"2014","unstructured":"Abecasis J, Ribeiras R, Gabriel H et\u00a0al (2014) Thrombus entrapment: the clue for coronary embolism. Eur Heart\u00a0J 35:2971","journal-title":"Eur Heart J"},{"key":"561_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","volume":"5","author":"S Agarwal","year":"2012","unstructured":"Agarwal S, Bajaj NS, Kumbhani DJ et al (2012) Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv 5:777\u2013789","journal-title":"JACC Cardiovasc. Interv."},{"key":"561_CR3","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1161\/01.CIR.86.6.1902","volume":"86","author":"ND Bridges","year":"1992","unstructured":"Bridges ND, Hellenbrand W, Latson L et\u00a0al (1992) Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 86:1902\u20131908","journal-title":"Circulation"},{"key":"561_CR4","first-page":"91","volume":"369","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL (2013) Patent foramen ovale and cryptogenic stroke. N\u00a0Engl J Med 369:91\u201392","journal-title":"N Engl J Med"},{"key":"561_CR5","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE et\u00a0al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N\u00a0Engl J Med 368:1092\u20131100","journal-title":"N Engl J Med"},{"key":"561_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/(SICI)1522-726X(199905)47:1<64::AID-CCD15>3.0.CO;2-6","volume":"47","author":"TO Cheng","year":"1999","unstructured":"Cheng TO (1999) Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv 47:64\u201366","journal-title":"Catheter Cardiovasc Interv"},{"key":"561_CR7","first-page":"134","volume-title":"Thrombose und Embolie: Vorlesung \u00fcber allgemeine Pathologie. Ein Handbuch f\u00fcr \u00c4rzte und Studierende","author":"J Cohnheim","year":"1877","unstructured":"Cohnheim J (1877) Thrombose und Embolie: Vorlesung \u00fcber allgemeine Pathologie. Ein Handbuch f\u00fcr \u00c4rzte und Studierende. Hirschwald, Berlin, S\u00a0134"},{"key":"561_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jcin.2012.01.011","volume":"5","author":"GP Devendra","year":"2012","unstructured":"Devendra GP, Rane AA, Krasuski RA (2012) Provoked exercise desaturation in patent foramen ovale & impact of percutaneous closure. JACC Cardiovasc Interv 5:416\u2013419","journal-title":"JACC Cardiovasc. Interv."},{"key":"561_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J et\u00a0al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N\u00a0Engl J Med 366:991\u2013999","journal-title":"N Engl J Med"},{"key":"561_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","volume":"59","author":"PT Hagen","year":"1984","unstructured":"Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59:17\u201320","journal-title":"Mayo Clin Proc"},{"key":"561_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijcard.2011.02.027","volume":"153","author":"OA Jarral","year":"2011","unstructured":"Jarral OA, Saso S, Vecht JA et al (2011) Does patent foramen ovale closure have an anti-arrhythmic effect? A meta-analysis. Int J Cardiol 153:4\u20139","journal-title":"Int J Cardiol"},{"key":"561_CR12","first-page":"383","volume":"75","author":"T King","year":"1974","unstructured":"King T, Mills N (1974) Nonoperative closure of atrial septal defects. Surgery 75:383\u2013388","journal-title":"Surgery"},{"key":"561_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/bmj.314.7082.701","volume":"314","author":"M Knauth","year":"1997","unstructured":"Knauth M, Ries S, Pohimann S et\u00a0al (1997) Cohort study of multiple brain lesions in sport divers: role of a\u00a0patent foramen ovale. BMJ 314:701\u2013705","journal-title":"BMJ"},{"key":"561_CR14","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1161\/01.CIR.97.19.1946","volume":"97","author":"S Konstantinides","year":"1998","unstructured":"Konstantinides S, Geibel A, Kasper W et\u00a0al (1998) Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 97:1946\u20131951","journal-title":"Circulation"},{"key":"561_CR15","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/S0140-6736(07)61731-0","volume":"370","author":"G Lowe","year":"2007","unstructured":"Lowe G (2007) Is venous thrombosis a\u00a0risk factor for aterial thrombosis? Lancet 370:1742\u20131744","journal-title":"Lancet"},{"key":"561_CR16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"JL Mas","year":"2017","unstructured":"Mas JL, Derumeaux G, Guillon B et\u00a0al (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N\u00a0Engl J Med 377:1011\u20131021","journal-title":"N Engl J Med"},{"key":"561_CR17","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/eurheartj\/ehw027","volume":"37","author":"HP Mattle","year":"2016","unstructured":"Mattle HP, Evers S, Hildick-Smith D et al (2016) Percutaneous closure of patent foramen ovale in migraine with aura, a\u00a0randomized controlled trial. Eur Heart\u00a0J 37:2029\u20132036","journal-title":"Eur Heart J"},{"key":"561_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/ccd.21651","volume":"72","author":"B Meier","year":"2008","unstructured":"Meier B (2008) Closure of the patent foramen ovale with dedicated Amplatzer occluders: closing in on a\u00a0mechanical vaccination. Catheter Cardiovasc Interv 72:80\u201381","journal-title":"Catheter Cardiovasc Interv"},{"key":"561_CR19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP et\u00a0al (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N\u00a0Engl J Med 368:1083\u20131091","journal-title":"N Engl J Med"},{"key":"561_CR20","first-page":"129196","volume":"2014","author":"B Meier","year":"2014","unstructured":"Meier B (2014) Patent foramen ovale and closure technique with the Amplatzer occluder. Scientifica (Cairo) 2014:129196","journal-title":"Scientifica (Cairo)"},{"key":"561_CR21","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jacc.2011.08.084","volume":"59","author":"D Pavoni","year":"2012","unstructured":"Pavoni D, Zanuttini D, Spedicato L et al (2012) Large interatrial thrombus-in-transit resulting in acute myocardial infarction complicated by atrioventricular block and cardiogenic shock. J\u00a0Am Coll Cardiol 59:1329","journal-title":"J Am Coll Cardiol"},{"key":"561_CR22","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.amjcard.2014.08.027","volume":"114","author":"C Pickett","year":"2014","unstructured":"Pickett C, Villines T, Ferguson M et\u00a0al (2014) Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a\u00a0patent foramen ovale. Am J Cardiol 114:1584\u20131589","journal-title":"Am J Cardiol"},{"key":"561_CR23","first-page":"162","volume":"25","author":"T Pilgrim","year":"2013","unstructured":"Pilgrim T, Meier B, Khattab A (2013) Death by patent foramen ovale in a\u00a0soccer player. J\u00a0Invasive Cardiol 25:162\u2013164","journal-title":"J Invasive Cardiol"},{"key":"561_CR24","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE et al (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N\u00a0Engl J Med 377:1022\u20131032","journal-title":"N Engl J Med"},{"key":"561_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-134-1-200101020-00009","volume":"134","author":"M Schwerzmann","year":"2001","unstructured":"Schwerzmann M, Seiler C, Lipp E et\u00a0al (2001) Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 134:21\u201324","journal-title":"Ann Intern Med"},{"key":"561_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1378\/chest.113.1.91","volume":"113","author":"H Shanoudy","year":"1998","unstructured":"Shanoudy H, Soliman A, Raggi P et\u00a0al (1998) Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest 113:91\u201396","journal-title":"Chest"},{"key":"561_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L Sondergaard","year":"2017","unstructured":"Sondergaard L, Kasner SE, Rhodes JF et\u00a0al (2017) Patent foramen cvale closure or antiplatelet therapy for cryptogenic stroke. N\u00a0Engl J Med 377:1033\u20131042","journal-title":"N Engl J Med"},{"key":"561_CR28","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(07)61745-0","volume":"370","author":"HT S\u00f8rensen","year":"2007","unstructured":"S\u00f8rensen HT, Horvath-Puho E, Pedersen L et al (2007) Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a\u00a020-year cohort study. Lancet 370:1773\u20131779","journal-title":"Lancet"},{"key":"561_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/ane.12456","volume":"133","author":"A Tanzi","year":"2016","unstructured":"Tanzi A, Onorato O, Casilli F et al (2016) Is the search for right-to-left shunt still worthwhile? Acta Neurol Scand 133:281\u2013288","journal-title":"Acta Neurol Scand"},{"key":"561_CR30","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1016\/j.jacc.2017.09.1105","volume":"70","author":"JM Tobis","year":"2017","unstructured":"Tobis JM, Charles A, Silberstein SD et\u00a0al (2017) Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM trial. J\u00a0Am Coll Cardiol 70:2766\u20132774","journal-title":"J Am Coll Cardiol"},{"key":"561_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","volume":"125","author":"A Wahl","year":"2012","unstructured":"Wahl A, J\u00fcni P, Mono ML et al (2012) Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation 125:803\u2013812","journal-title":"Circulation"},{"key":"561_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/hrt.2009.181156","volume":"96","author":"A Wahl","year":"2010","unstructured":"Wahl A, Praz F, Tai T et\u00a0al (2010) Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 96:967\u2013973","journal-title":"Heart"},{"key":"561_CR33","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/S0140-6736(00)03160-3","volume":"356","author":"PT Wilmshurst","year":"2000","unstructured":"Wilmshurst PT, Nightingale S, Walsh KP et al (2000) Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356:1648\u20131651","journal-title":"Lancet"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-019-0561-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-019-0561-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-019-0561-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:25:30Z","timestamp":1583799930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-019-0561-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1007\/s00063-019-0561-z","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"assertion":[{"value":"17 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Meier erhielt Vortragshonorare von Abbott und Lepu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}